Trials / Conditions / EGFR Exon 20 Insertion Mutation
EGFR Exon 20 Insertion Mutation
5 registered clinical trials studyying EGFR Exon 20 Insertion Mutation — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion NCT06247826 | Groupe Francais De Pneumo-Cancerologie | N/A |
| Recruiting | To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mut NCT06192849 | Juan LI, MD | Phase 2 |
| Recruiting | Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer NCT06706713 | BeBetter Med Inc | Phase 2 |
| Terminated | (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations NCT05241873 | Blueprint Medicines Corporation | Phase 1 |
| Terminated | Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumo NCT03805841 | Rain Oncology Inc | Phase 2 |